General Psychiatry - Articles - Page 134

Breast Feeding and Psychiatric Medications: An Overview

February 1, 2009

Dhwani Shah, MD

Any discussion of psychiatric medications and breastfeeding must begin with the benefits of breastfeeding, which are substantial. While all psychotropic medications enter the breast milk, medication exposure for a nursing infant is much less than the exposure to a fetus during pregnancy.

Risperidone Shows Mixed Results in Augmenting Antidepressant Treatment

February 1, 2009

Section editor, Glen Spielmans, PhD

A recent trial examined the impact of augmenting antidepressant treatment with risperidone. Participants had not shown a treatment response after taking an antidepressant for at least five weeks, and were then randomly assigned to receive either risperidone or placebo augmentation along with the same dose of their antidepressant.

Headache Is a Risk Factor For Suicidality

February 1, 2009

John O’Reardon, MD

The original Epidemiological Catchment Area (ECA) study (based on interviews conducted in the 1980s) examined the prevalence of mental disorders among adults in five American cities. Taking a fresh look, researchers examined data from 6,832 adults who resided in the community in order to ascertain the relationship between headache and suicidality.

Adverse Effects of SSRIs in Pregnancy

February 1, 2009

Dr. Hendrick, earlier this decade, most experts felt that SSRIs were relatively safe in pregnancy, but lately the pendulum seems to be swinging in the other direction. What do you consider to be the major risks of SSRIs in pregnancy?

Learning Objectives, Psychiatric Medication in Pregnancy and Lactation, TCPR, February 2009

February 1, 2009

After reading these articles, you should be able to…

Transcranial Magnetic Stimulation is Approved. Now What?

January 1, 2009

Daniel Carlat, MD

One year ago we reviewed the status of transcranial magnetic stimulation for depression, and concluded with the following TCPR Verdict: “TMS for depression: Approval is highly unlikely.” We were wrong.

The New Brain Devices in Psychiatry: A Brief Review

January 1, 2009

Dhwani Shah, MD

In this issue of TCPR, we focus on TMS (Transcranial Magnetic Stimulation), which has just been approved for treatment resistant depression. There are also other brain devices in various stages of research and development. Here is a quick run-down of four of them.

SSRI Discontinuation Linked to Poor Outcomes

January 1, 2009

Dhwani Shah, MD

Section editor, Glen Spielmans, PhD

Dhwani Shah, MD. Associate Clinical Professor University of Pennsylvania Department of Psychiatry.
Dr. Shah reports no financial relationships with any commercial companies related to this article.

In a naturalistic study, researchers identified 87 patients in an outpatient clinic who had taken SSRIs for depression and who were clinically stable for at least five years. After five years, 27 patients elected to discontinue SSRIs, and 60 elected to continue.

The Role of Etiquette-Based Medicine

January 1, 2009

Glen Spielmans, PhD

Section editor, Glen Spielmans, PhD

Dr. Spielmans has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.

We’ve all been told from time to time that we should mind our manners. A Boston psychiatrist, Michael Kahn, suggests that manners are not limited to dinner parties; rather, he calls for “etiquette based medicine.”

EXPERT Q&A

Practical Issues in Using Transcranial Magnetic Stimulation

January 1, 2009

John O'Reardon, MD

TCPR-January-2009-TMS_JohnO'ReadonMD_Headshot.png

John O'Reardon, MD. Associate Professor of Psychiatry, University of Pennsylvania Health System.

Dr. O’Reardon has disclosed that he has received research grants from Neuronetics, Cyberonics, Cerex Biopharma, and Pfizer, and is on the speaker's bureaus of Eli Lilly and Bristol-Myers Squibb. Dr. Carlat has found that there is no evidence of commercial bias in this educational activity.

Dr. O’Reardon, the FDA recently approved TMS for depression. Can you clarify exactly what this approval was for?

General Psychiatry
RSS

Breast Feeding and Psychiatric Medications: An Overview

Risperidone Shows Mixed Results in Augmenting Antidepressant Treatment

Headache Is a Risk Factor For Suicidality

Adverse Effects of SSRIs in Pregnancy

Learning Objectives, Psychiatric Medication in Pregnancy and Lactation, TCPR, February 2009

Transcranial Magnetic Stimulation is Approved. Now What?

The New Brain Devices in Psychiatry: A Brief Review

SSRI Discontinuation Linked to Poor Outcomes

The Role of Etiquette-Based Medicine

Practical Issues in Using Transcranial Magnetic Stimulation

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

Psychopharm Secrets: Coming Off Meds

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

About

Shop Online

Newsletters

Contact

Follow Us

General Psychiatry RSS

About

Shop Online

Newsletters

Contact

Follow Us

General Psychiatry
RSS